Squarepoint’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.43M Buy
+109,388
New +$2.43M ﹤0.01% 1083
2025
Q1
Sell
-80,870
Closed -$1.07M 2739
2024
Q4
$1.07M Buy
80,870
+36,365
+82% +$481K ﹤0.01% 1490
2024
Q3
$1.49M Buy
44,505
+33,320
+298% +$1.12M ﹤0.01% 1252
2024
Q2
$280K Sell
11,185
-482
-4% -$12.1K ﹤0.01% 1999
2024
Q1
$263K Sell
11,667
-6,256
-35% -$141K ﹤0.01% 1980
2023
Q4
$384K Sell
17,923
-34,530
-66% -$740K ﹤0.01% 1842
2023
Q3
$942K Buy
52,453
+20,968
+67% +$377K ﹤0.01% 1330
2023
Q2
$640K Buy
31,485
+1,383
+5% +$28.1K ﹤0.01% 1485
2023
Q1
$655K Buy
30,102
+13,319
+79% +$290K ﹤0.01% 1350
2022
Q4
$520K Sell
16,783
-21,926
-57% -$679K ﹤0.01% 1441
2022
Q3
$987K Sell
38,709
-9,202
-19% -$235K 0.01% 1087
2022
Q2
$973K Buy
+47,911
New +$973K 0.01% 1060
2020
Q4
Sell
-20,473
Closed -$302K 2498
2020
Q3
$302K Buy
+20,473
New +$302K ﹤0.01% 1674
2020
Q2
Sell
-13,086
Closed -$185K 2130
2020
Q1
$185K Sell
13,086
-2,307
-15% -$32.6K ﹤0.01% 1495
2019
Q4
$250K Buy
15,393
+3,608
+31% +$58.6K ﹤0.01% 2047
2019
Q3
$412K Buy
11,785
+2,475
+27% +$86.5K ﹤0.01% 1655
2019
Q2
$525K Sell
9,310
-8,290
-47% -$467K 0.01% 1599
2019
Q1
$1.29M Buy
17,600
+7,736
+78% +$565K 0.01% 967
2018
Q4
$629K Sell
9,864
-8,190
-45% -$522K 0.01% 1123
2018
Q3
$1.8M Buy
18,054
+3,454
+24% +$345K 0.02% 763
2018
Q2
$1.04M Buy
14,600
+12,300
+535% +$874K 0.01% 879
2018
Q1
$239K Sell
2,300
-6,313
-73% -$656K ﹤0.01% 1414
2017
Q4
$868K Buy
+8,613
New +$868K 0.02% 883